Abstract
This present review submitted high-performance liquid chromatography (HPLC) methods for determining the presence of meloxicam used in clinical treatment within various fields of application, including biological samples and pharmaceutical formulations, between 1990 and 2011.
Meloxicam is a cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAIDs), which is the group most often used in human health care. We compared the methods from the standpoint of sensitivity. HPLC methods with MS/MS detection have become the method of choice in bioanalytical applications.
Keywords: Meloxicam, HPLC, Review, Pharmaceutical preparations, Biological samples, cyclooxygenase, NSAIDs, sensitivity, hemorrhagia, physiological, methylthiazole system
Current Pharmaceutical Analysis
Title:A Review of HPLC Methods Used for Determining the Presence of Meloxicam
Volume: 9 Issue: 1
Author(s): Monika Brezovska, Josef Jampilek and Radka Opatrilova
Affiliation:
Keywords: Meloxicam, HPLC, Review, Pharmaceutical preparations, Biological samples, cyclooxygenase, NSAIDs, sensitivity, hemorrhagia, physiological, methylthiazole system
Abstract: This present review submitted high-performance liquid chromatography (HPLC) methods for determining the presence of meloxicam used in clinical treatment within various fields of application, including biological samples and pharmaceutical formulations, between 1990 and 2011.
Meloxicam is a cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAIDs), which is the group most often used in human health care. We compared the methods from the standpoint of sensitivity. HPLC methods with MS/MS detection have become the method of choice in bioanalytical applications.
Export Options
About this article
Cite this article as:
Brezovska Monika, Jampilek Josef and Opatrilova Radka, A Review of HPLC Methods Used for Determining the Presence of Meloxicam, Current Pharmaceutical Analysis 2013; 9 (1) . https://dx.doi.org/10.2174/1573412911309010010
DOI https://dx.doi.org/10.2174/1573412911309010010 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Advancements in the Treatment and Repair of Tendon Injuries
Current Tissue Engineering (Discontinued) Editorial (Thematic Issue:Nanotechnology for Drug Delivery: Part III)
Current Pharmaceutical Design Chemical Biology: Past, Present and Future
Current Chemical Biology Dihydrofolate Reductase Gene Variations in Susceptibility to Disease and Treatment Outcomes
Current Genomics The Role of P2X Receptors in Bone Biology
Current Medicinal Chemistry Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics Non-histone Methylation of SET7/9 and its Biological Functions
Recent Patents on Anti-Cancer Drug Discovery Radionuclides Used in Nuclear Medicine Therapy – From Production to Dosimetry
Current Medical Imaging The In-Situ One-Step Synthesis of a PDC Macromolecular Pro-Drug and the Fabrication of a Novel Core-Shell Micell
Current Pharmaceutical Design Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma
Current Cancer Drug Targets Therapeutic Transfer of DNA Encoding Adenoviral E1A
Recent Patents on Anti-Cancer Drug Discovery Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Current Medicinal Chemistry The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy
Current Drug Targets Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design Preclinical Evidence on the Anticancer Properties of Food Peptides
Protein & Peptide Letters Radiolabelled Peptides: Eon in Radiopharmaceutical
Current Radiopharmaceuticals Aerosol Delivery in the Treatment of Lung Cancer
Current Cancer Drug Targets Attenuation of ERK/RSK2-Driven NFκB Gene Expression and Cancer Cell Proliferation by Kurarinone, a Lavandulyl Flavanone Isolated from Sophora flavescens Ait. Roots
Endocrine, Metabolic & Immune Disorders - Drug Targets New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry